Lamotrigine Tablet, Orally Disintegrating
Product Images NDC 49884-487

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 49884-487). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lamotrigine (Lamotrigine Tablet 1)

FDA Label Image

Lamotrigine (Lamotrigine Tablet 10)

Lamotrigine (Lamotrigine Tablet 10)
This text is describing the medication Lamotrigine Orally Disintegrating Tablets, which are taken once or every other day depending on the week of treatment. Patients who take valproate may need to take a different dosage. Patients are urged to read the accompanying Medication Guide for Lamotrigine Orally Disintegrating Tablets and seek advice from their doctor or pharmacist if they have questions. The medication is formulated to taste better and dissolve quickly. The text provides information on dosage and guides patients to carefully verify the product dispensed.*
FDA Label Image

Lamotrigine (Lamotrigine Tablet 11)

Lamotrigine (Lamotrigine Tablet 11)
This is medication information including dosage information, storage instructions, and manufacturer details for a product with the NDC number 49884-881-09. It is available in tablet form, with a strength of 50 mg and 100 mg. It is important to keep this medication out of the reach of children, and it should be stored at temperatures between 20°C to 25°C (68'F to 77°F), with excursions allowed between 15°C and 30°C (59°F and 86°F). The manufacturer is Par Pharmaceuticals from Chestnut Ridge, NY, and the product is made in India by Par Formulations Private Limited.*
FDA Label Image

Lamotrigine (Lamotrigine Tablet 12)

Lamotrigine (Lamotrigine Tablet 12)
This is a medication guide for Lamotrigine orally disintegrating tablets. The recommended dosage varies from 50mg to 100mg per day depending on the patient. The tablets are formulated to dissolve quickly and mask the bitter taste of lamotrigine. The guide advises patients to read the accompanying medication guide in full before taking the medication and to keep it until the medication is finished. The backside of the panel provides instructions for the third week of treatment.*
FDA Label Image

Lamotrigine (Lamotrigine Tablet 13)

Lamotrigine (Lamotrigine Tablet 13)
This is a description of a patient titration kit for Lamotrigine, which is an orally disintegrating tablet used as a medication for patients who do not take carbamazepine, phenytoin, phenobarbital, primidone or valproate. The kit consists of tablets with different strengths - 25mg, 50mg, and 100mg - to be taken once a day as instructed by the doctor. The medication guide must be provided to the patient and instructions should be read carefully before administering the medication. The tablets are formulated to mask the bitter taste of lamotrigine and dissolve rapidly. Instructions on how to administer the tablet are provided for weeks 1, 2, 3, and 4.*
FDA Label Image

Lamotrigine (Lamotrigine Tablet 14)

Lamotrigine (Lamotrigine Tablet 14)
This text provides instructions for using Lamotrigine Orally Disintegrating Tablets, a medication for patients not taking certain other drugs. The tablets should be exposed by opening the package and gently placing one in the mouth, where it will dissolve and can be swallowed with or without water. The text also includes dosage and storage information, as well as the manufacturer's contact information.*
FDA Label Image

Lamotrigine (Lamotrigine Tablet 2)

FDA Label Image

Lamotrigine (Lamotrigine Tablet 3)

FDA Label Image

Lamotrigine-diagram.jpg (Lamotrigine Tablet 4)

Lamotrigine-diagram.jpg (Lamotrigine Tablet 4)
This is a list of four different medications with their dosages and appearance. The first one is a white pill with the imprint of "NT" on one side and "123" on the other side, with a dosage of 25 mg. The second one is a white pill with the imprint of "EP" on one side and "191" on the other side, with a dosage of 50 mg. The third one is a peach pill with the imprint of "E" on one side and "432" on the other side, with a dosage of 100 mg. The fourth one is a white pill with the imprint of "EP" on one side and "433" on the other side, with a dosage of 200 mg.*
FDA Label Image

Lamotrigine (Lamotrigine Tablet 5)

FDA Label Image

Lamotrigine (Lamotrigine Tablet 6)

Lamotrigine (Lamotrigine Tablet 6)
This is a medication with the National Drug Code (NDC) 49884-485-11 which contains 50 mg of Lamotrigine. It is in the form of orally disintegrating tablets. No additional information is provided.*
FDA Label Image

Lamotrigine (Lamotrigine Tablet 7)

FDA Label Image

Lamotrigine (Lamotrigine Tablet 8)

Lamotrigine (Lamotrigine Tablet 8)
This is a description of lamotrigine, an orally disintegrating medication available as 200mg tablets. It is intended as a maintenance pack for patients who are already taking lamotrigine and not for testing purposes. The rest of the text is either illegible or not available.*
FDA Label Image

Lamotrigine (Lamotrigine Tablet 9)

Lamotrigine (Lamotrigine Tablet 9)
This is a medication guide for Lamotrigine Orally Disintegrating Tablets, which are used to treat epilepsy and bipolar disorder. The medication guide contains instructions on how to take the tablets in weeks 3 and 4 of treatment and advises patients to read the accompanying medication guide before taking the tablets. The medication is available in 25mg tablets, and patients taking valproate may need to adjust their dosage. The tablets are designed to dissolve quickly and mask the bitter taste of the active ingredient. The label also includes a caution to verify the product dispensed.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.